Literature DB >> 33752211

Cognitive Impairment after Lacunar Stroke and the Risk of Recurrent Stroke and Death.

Abraham Kwan1, Jingkai Wei1, N Maritza Dowling2, Melinda C Power1, Zurab Nadareishvili3,4.   

Abstract

INTRODUCTION: Patients with poststroke cognitive impairment appear to be at higher risk of recurrent stroke and death. However, whether cognitive impairment after lacunar stroke is associated with recurrent stroke and death remains unclear. We assessed whether global or domain-specific cognitive impairment after lacunar stroke is associated with recurrent stroke and death.
METHODS: We considered patients from the Secondary Prevention of Small Subcortical Strokes (SPS3) trial with a baseline cognitive exam administered in English by certified SPS3 personnel, 14-180 days after qualifying lacunar stroke. We considered a baseline score of ≤86 on the Cognitive Assessment Screening Instrument to indicate global cognitive impairment, <10 on the Clock Drawing on Command test to indicate executive function impairment, and domain-specific summary scores in the lowest quartile to indicate memory and nonmemory impairment. We used Cox proportional hazards models to estimate the association between poststroke cognitive impairment and subsequent risk of recurrent stroke and death.
RESULTS: The study included 1,528 participants with a median enrollment time of 62 days after qualifying stroke. During a mean follow-up of 3.9 years, 11.4% of participants had recurrent stroke and 8.2% died. In the fully adjusted models, memory impairment was independently associated with an increased risk of recurrent stroke (hazard ratio, 1.48; 95% confidence interval [95% CI]: 1.04-2.09) and death (hazard ratio, 1.87; 95% CI: 1.25-2.79). Global impairment (hazard ratio, 1.66; 95% CI: 1.06-2.59) and nonmemory impairment (hazard ratio, 1.74; 95% CI: 1.14-2.67) were associated with an increased risk of death. DISCUSSION/
CONCLUSION: After lacunar stroke, memory impairment was an independent predictor of recurrent stroke and death, while global and nonmemory impairment were associated with death. Cognitive screening in lacunar stroke may help identify populations at higher risk of recurrent stroke and death.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Cognitive impairment; Cognitive testing; Cohort study; Lacunar stroke

Mesh:

Year:  2021        PMID: 33752211      PMCID: PMC8266725          DOI: 10.1159/000514261

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  31 in total

1.  Long-term disability after lacunar stroke: secondary prevention of small subcortical strokes.

Authors:  Mandip S Dhamoon; Leslie A McClure; Carole L White; Kamakshi Lakshminarayan; Oscar R Benavente; Mitchell S V Elkind
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

2.  Cognitive performance following lacunar stroke in Spanish-speaking patients: results from the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Ana M Roldan; Antonio Arauz; Jorge Tapia; Raymond Costello; Leslie A McClure; Robert G Hart; Oscar R Benavente
Journal:  Int J Stroke       Date:  2015-06       Impact factor: 5.266

3.  Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

Authors:  Oscar R Benavente; Robert G Hart; Leslie A McClure; Jeffrey M Szychowski; Christopher S Coffey; Lesly A Pearce
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

4.  Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.

Authors:  Ashkan Shoamanesh; Lesly A Pearce; Carlos Bazan; Luciana Catanese; Leslie A McClure; Mukul Sharma; Joan Marti-Fabregas; David C Anderson; Carlos S Kase; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2017-07-19       Impact factor: 10.422

5.  The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients.

Authors:  Kaavya Narasimhalu; Sandy Ang; Deidre Anne De Silva; Meng-Cheong Wong; Hui-Meng Chang; Kee-Seng Chia; Alexander P Auchus; Christopher P Chen
Journal:  Stroke       Date:  2011-02-17       Impact factor: 7.914

6.  Cognitive impairment in lacunar strokes: the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Raymond Costello; Leslie A McClure; Stephen L Holliday; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

7.  Alcohol consumption and risk of stroke: a meta-analysis.

Authors:  Kristi Reynolds; Brian Lewis; John David L Nolen; Gregory L Kinney; Bhavani Sathya; Jiang He; Brian L Lewis
Journal:  JAMA       Date:  2003-02-05       Impact factor: 56.272

8.  Cognitive impairment predicts poststroke death in long-term follow-up.

Authors:  N K J Oksala; H Jokinen; S Melkas; A Oksala; T Pohjasvaara; M Hietanen; R Vataja; M Kaste; P J Karhunen; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-07-19       Impact factor: 10.154

9.  Leukoaraiosis more than dementia is a predictor of stroke recurrence.

Authors:  H Hénon; P Vroylandt; I Durieu; F Pasquier; D Leys
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

Review 10.  Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes.

Authors:  Stephen David James Makin; Sarah Turpin; Martin S Dennis; Joanna M Wardlaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-01       Impact factor: 10.154

View more
  2 in total

1.  Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes.

Authors:  Chengcheng Zhang; Fengqin Qin; Xiaojing Li; Xiangdong Du; Tao Li
Journal:  BMC Med       Date:  2022-06-23       Impact factor: 11.150

2.  Hip Osteoarthritis and the Risk of Lacunar Stroke: A Two-Sample Mendelian Randomization Study.

Authors:  Yi Shen; Fuju Li; Lina Cao; Yunyun Wang; Jing Xiao; Xiaoyi Zhou; Tian Tian
Journal:  Genes (Basel)       Date:  2022-09-03       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.